Ignite Creation Date:
2024-05-05 @ 9:54 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00986206
Status:
COMPLETED
Last Update Posted:
2018-01-05
First Post:
2009-09-26
Brief Title:
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Sponsor:
Women and Infants Hospital of Rhode Island
Organization:
Women and Infants Hospital of Rhode Island
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Cancer |
| brca1 Mutation Carrier |
| brca2 Mutation Carrier |
Keywords:
| Name | View |
|---|---|
| stage IV ovarian epithelial cancer | View |
| ovarian epithelial cancer | View |
| BRCA1 mutation carrier | View |
| BRCA2 mutation carrier | View |
| stage IA ovarian epithelial cancer | View |
| stage IB ovarian epithelial cancer | View |
| stage IC ovarian epithelial cancer | View |
| stage IIA ovarian epithelial cancer | View |
| stage IIB ovarian epithelial cancer | View |
| stage IIC ovarian epithelial cancer | View |
| stage IIIA ovarian epithelial cancer | View |
| stage IIIB ovarian epithelial cancer | View |
| stage IIIC ovarian epithelial cancer | View |